COMMUNIQUÉS West-GlobeNewswire

CohBar Announces the Appointment of Dr. Phyllis Gardner to its Board of Directors
11/02/2019
MENLO PARK, Calif., Feb. 11, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today announced [...]
Driven Deliveries Inc. Expands California Cannabis Delivery Platform
11/02/2019
Company now has 4 retail partners covering all major markets of California SAN DIEGO, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Driven Deliveries, Inc., (DRVD), the world’s first and only publicly traded cannabis delivery [...]
Eve & Co Announces Retail Release of Dried Flower
11/02/2019
TORONTO, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (TSX-V: EVE; OTCQB: EEVVF) (“Eve & Co” or the “Company”) is pleased to announce that a product line of pre-rolls is now available for purchase in [...]
Yield Growth Expanding Product Lines & Distribution Footprint-- CFN Media
11/02/2019
SEATTLE, Feb. 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Hemispherx Biopharma Announces Commencement of a New 45 Subject Clinical Trial Combining Ampligen and Merck’s Keytruda in the Treatment of Recurrent Ovarian Cancer
11/02/2019
OCALA, Fla., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB), an immuno-pharma company focused on unmet medical needs in immunology and oncology, announced today the start at the UPMC [...]
Former Procter & Gamble Executive Raj Pudipeddi Joins Align Technology as Senior Vice President and CMO
11/02/2019
SAN JOSE, Calif., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN) today announced that Raj Pudipeddi has joined the Company as senior vice president and CMO reporting to Joe Hogan, Align [...]
Adverum Biotechnologies Announces Presentation of Preclinical Long-Term Safety Data of ADVM-022 at 2019 Angiogenesis, Exudation, and Degeneration Conference
11/02/2019
Data demonstrates long-term expression of ADVM-022, an intravitreally delivered gene therapy currently in phase 1 for wet AMD, does not affect retinal morphology in non-human primates Initial long-term preclinical [...]
Avalon GloboCare Announces Breakthrough in Identifying Human Angiogenic Exosomes/Extracellular Vesicles (EV) Derived from Endothelial Cells
11/02/2019
Angiogenic exosomes containing angiogenic factors developed to promote new blood vessel formation and tissue regeneration upon release from exosomes. Results from Avalon’s co-development program with Weill Cornell [...]
Progenics Acquires AZEDRA® (iobenguane I 131) Radiopharmaceutical Manufacturing Facility
11/02/2019
NEW YORK, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company developing innovative medicines and imaging analysis technology for targeting and treating cancer, today [...]
PSIQ Forms CannBerry Tek to Develop a Cannabis Genetic Seed Bank to Create Proprietary Cannabis Seed Types and Strains
11/02/2019
SUNRISE, Fla., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) announces the formation of CannBerry Tek, Inc. as a Hi-tech innovative Biotechnology Company to manage various Research & [...]
Advantis Corp. Moves Forward with Plans to Establish Los Angeles Presence, Partners with Statewide Distributor and Manufacturer
11/02/2019
NEWPORT BEACH, CA, Feb. 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – ADVANTIS CORPORATION (OTC PINK: ADVT) announced today that it is resuming negotiations to establish a location in Los Angeles to package and [...]
AIT Therapeutics Announces Appointment of Robert F. Carey to Board of Directors
11/02/2019
GARDEN CITY, N.Y. and REHOVOT, Israel, Feb. 11, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTCQB: AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO [...]
Lumere Closes Strategic Growth Capital Funding
11/02/2019
Investment Led by Heritage Group with Participation from Clients Spectrum Health Ventures and HCA Healthcare CHICAGO, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Lumere, Inc., a leading provider of evidence-based analytics and [...]
Active Biotech's partner NeoTX enters clinical collaboration with AstraZeneca to evaluate ANYARA in combination with IMFINZI® (durvalumab) in the upcoming Phase 1b/2 study
11/02/2019
PRESS RELEASE Lund Sweden, February 11 2019 - Active Biotech (NASDAQ STOCKHOLM: ACTI) announces that their partner NeoTX enters a clinical collaboration with AstraZeneca Group Plc (NYSE: AZN) global biologics research [...]
Eton Pharmaceuticals Enters Into License Agreement for Two Branded Hospital Product Candidates
11/02/2019
Transaction adds an additional potential 2019 product launch to Eton’s pipeline ET-202 NDA was submitted in December 2018; PDUFA date expected to be in Q4 2019 ET-203 NDA expected to be submitted by Q3 2019 DEER PARK, [...]
Nemaura Announces Dr. Fred Schaebsdau to Lead Strategy and Business Development
11/02/2019
Dr. Schaebsdau to Advance European Launch of SugarBEAT ® Continuous Glucose Monitor Nemaura Preparing U.S. FDA 510(k) Submission Loughborough, England – February 11, 2019 – Nemaura Medical, Inc. (NASDAQ: NMRD) [...]
CMR Surgical announces the appointment of Ingeborg Øie as Chief Financial Officer
11/02/2019
CMR Surgical Limited ("CMR Surgical" or the "Company") CMR Surgical announces the appointment of Ingeborg Øie as Chief Financial Officer Cambridge, UK, 11 February 2019 : CMR Surgical Ltd, the British company developing [...]
Delcath Announces Health Authority Approval for CHEMOSAT in Brazil
11/02/2019
Discussions Underway With Potential Commercialization Partners NEW YORK, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and [...]
IntelGenx Granted Japanese Patent for RIZAPORT® VersaFilm™
11/02/2019
SAINT LAURENT, Quebec, Feb. 11, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that it has received a Decision to Grant notice from [...]

Pages